Mandy van Brakel - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2026

Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in bloodKarlijn de Joode, Hayri E Balcioglu, Mandy van Brakel, et al.

Cancer Research|February 26, 2025

CXCL10 Secreted by Pericytes Mediates TNFα-Induced Vascular Leakage in Tumors and Enhances Extravasation of Nanoparticle-Based ChemotherapeuticsAnn L B Seynhaeve, Hui Liu, Marjolein I Priester, et al.

Cancers|April 3, 2021

Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 MonotherapyMirjam de With, Daan P Hurkmans, Esther Oomen-de Hoop, et al.

Cancer Immunology, Immunotherapy : CII|August 17, 2022

A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancerMaud Rijnders, Debbie G J Robbrecht, Astrid A M Oostvogels, et al.

Cancer Immunology Research|May 6, 2026

Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC After Immune Checkpoint BlockadeKatrien L A Quintelier, Maaike M Hofman, Mandy van Brakel, et al.

Journal for Immunotherapy of Cancer|June 10, 2019

CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabAndre Kunert, Edwin A Basak, Daan P Hurkmans, et al.

Cancer Discovery|August 22, 2024

TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast CancerDian Kortleve, Dora Hammerl, Mandy van Brakel, et al.

Journal for Immunotherapy of Cancer|January 11, 2021

Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2026

Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in bloodKarlijn de Joode, Hayri E Balcioglu, Mandy van Brakel, et al.

Cancer Research|February 26, 2025

CXCL10 Secreted by Pericytes Mediates TNFα-Induced Vascular Leakage in Tumors and Enhances Extravasation of Nanoparticle-Based ChemotherapeuticsAnn L B Seynhaeve, Hui Liu, Marjolein I Priester, et al.

Cancers|April 3, 2021

Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 MonotherapyMirjam de With, Daan P Hurkmans, Esther Oomen-de Hoop, et al.

Cancer Immunology, Immunotherapy : CII|August 17, 2022

A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancerMaud Rijnders, Debbie G J Robbrecht, Astrid A M Oostvogels, et al.

Cancer Immunology Research|May 6, 2026

Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC After Immune Checkpoint BlockadeKatrien L A Quintelier, Maaike M Hofman, Mandy van Brakel, et al.

Journal for Immunotherapy of Cancer|June 10, 2019

CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabAndre Kunert, Edwin A Basak, Daan P Hurkmans, et al.

Cancer Discovery|August 22, 2024

TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast CancerDian Kortleve, Dora Hammerl, Mandy van Brakel, et al.

Journal for Immunotherapy of Cancer|January 11, 2021

Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.

Pageof 2